PT1007717E - Processos e composicoes para terapias do cancro,utilizando genes que codificam o interferao-beta - Google Patents

Processos e composicoes para terapias do cancro,utilizando genes que codificam o interferao-beta

Info

Publication number
PT1007717E
PT1007717E PT98944526T PT98944526T PT1007717E PT 1007717 E PT1007717 E PT 1007717E PT 98944526 T PT98944526 T PT 98944526T PT 98944526 T PT98944526 T PT 98944526T PT 1007717 E PT1007717 E PT 1007717E
Authority
PT
Portugal
Prior art keywords
compositions
genes
code
processes
cancer therapies
Prior art date
Application number
PT98944526T
Other languages
English (en)
Inventor
James G Barsoum
Qin Xiao-Qiang
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc filed Critical Biogen Inc
Publication of PT1007717E publication Critical patent/PT1007717E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT98944526T 1997-08-29 1998-08-25 Processos e composicoes para terapias do cancro,utilizando genes que codificam o interferao-beta PT1007717E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5725497P 1997-08-29 1997-08-29

Publications (1)

Publication Number Publication Date
PT1007717E true PT1007717E (pt) 2006-06-30

Family

ID=22009467

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98944526T PT1007717E (pt) 1997-08-29 1998-08-25 Processos e composicoes para terapias do cancro,utilizando genes que codificam o interferao-beta

Country Status (24)

Country Link
EP (1) EP1007717B8 (pt)
JP (3) JP4124565B2 (pt)
KR (1) KR100699285B1 (pt)
CN (1) CN100342019C (pt)
AT (1) ATE316145T1 (pt)
AU (1) AU740428B2 (pt)
BR (1) BR9812138A (pt)
CA (1) CA2300480C (pt)
CY (1) CY1105029T1 (pt)
CZ (2) CZ299095B6 (pt)
DE (1) DE69833264T2 (pt)
DK (1) DK1007717T3 (pt)
EA (1) EA003256B1 (pt)
EE (1) EE04873B1 (pt)
ES (1) ES2257817T3 (pt)
HU (1) HU224422B1 (pt)
IL (2) IL134593A0 (pt)
IS (1) IS2318B (pt)
NO (1) NO20000990L (pt)
NZ (1) NZ503401A (pt)
PT (1) PT1007717E (pt)
SK (1) SK286821B6 (pt)
TR (1) TR200000532T2 (pt)
WO (1) WO1999010516A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1363676E (pt) * 2001-01-22 2007-06-22 Biogen Idec Inc Processo para aumentar a libertação de um ácido nucleico terapêutico
US8058248B2 (en) * 2001-04-26 2011-11-15 The United States Of America As Represented By The Secretary Of Agriculture Foot and mouth disease virus vaccine comprising interferons
CN1388248A (zh) * 2001-05-25 2003-01-01 钱其军 高效表达干扰素的肿瘤细胞内特异性增殖的腺病毒及其构建方法
EP1835032A1 (en) * 2006-03-14 2007-09-19 Université de Liège A self-inactivating recombinant lentiviral vector for the inhibition of HIV replication
MD35Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de apreciere a riscului dezvoltării carcinomului neinvaziv in situ al glandei mamare
MD24Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului neinvaziv al glandei mamare
MD23Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului lobular in situ neinvaziv al glandei mamare
MD36Z (ro) * 2008-12-02 2010-01-31 Василе ЖОВМИР Metodă de tratament diferenţiat al carcinomului ductal in situ neinvaziv al glandei mamare
CN103505722B (zh) * 2012-06-19 2016-04-13 苏州丁孚靶点生物技术有限公司 干扰素在治疗/预防对常规抗肿瘤疗法有抗性的肿瘤中的用途及相关的产品和方法
WO2017214706A1 (en) * 2016-06-15 2017-12-21 Tissue Regeneration Therapeutics Inc. Anti-cancer use of genetically modified human umbilical cord perivascular cells (hucpvc)
CA3142425A1 (en) * 2019-06-01 2020-12-10 Sivec Biotechnologies, Llc A bacterial platform for delivery of gene-editing systems to eukaryotic cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2122519C (en) * 1994-04-29 2001-02-20 Rudolf Edgar Dr. Falk Cancer treatment and metastasis prevention
US6204052B1 (en) * 1994-08-16 2001-03-20 Introgene B.V. Adenoviral vectors with reduced TNF response and partial E3 region deletion
US5952221A (en) * 1996-03-06 1999-09-14 Avigen, Inc. Adeno-associated virus vectors comprising a first and second nucleic acid sequence

Also Published As

Publication number Publication date
IS5374A (is) 2000-02-11
EP1007717B1 (en) 2006-01-18
JP3953458B2 (ja) 2007-08-08
DE69833264D1 (de) 2006-04-06
SK286821B6 (sk) 2009-06-05
WO1999010516A2 (en) 1999-03-04
EP1007717A2 (en) 2000-06-14
ATE316145T1 (de) 2006-02-15
NO20000990L (no) 2000-05-02
JP4124565B2 (ja) 2008-07-23
ES2257817T3 (es) 2006-08-01
CA2300480C (en) 2010-01-05
KR100699285B1 (ko) 2007-03-26
BR9812138A (pt) 2000-07-18
AU9205198A (en) 1999-03-16
CZ2000733A3 (cs) 2000-06-14
CA2300480A1 (en) 1999-03-04
IL134593A (en) 2007-06-17
CZ297314B6 (cs) 2006-11-15
NZ503401A (en) 2003-01-31
CZ299095B6 (cs) 2008-04-23
SK2482000A3 (en) 2000-08-14
KR20010023511A (ko) 2001-03-26
CN100342019C (zh) 2007-10-10
TR200000532T2 (tr) 2000-11-21
JP2005225888A (ja) 2005-08-25
IS2318B (is) 2007-11-15
NO20000990D0 (no) 2000-02-28
JP2001514010A (ja) 2001-09-11
DK1007717T3 (da) 2006-05-29
CY1105029T1 (el) 2010-03-03
HUP0002913A3 (en) 2003-08-28
JP4219335B2 (ja) 2009-02-04
JP2004155786A (ja) 2004-06-03
EE04873B1 (et) 2007-08-15
CN1271391A (zh) 2000-10-25
AU740428B2 (en) 2001-11-01
WO1999010516A3 (en) 1999-05-06
IL134593A0 (en) 2001-04-30
DE69833264T2 (de) 2006-09-28
HUP0002913A2 (hu) 2000-12-28
EA200000270A1 (ru) 2000-10-30
EP1007717B8 (en) 2006-05-03
EE200000102A (et) 2000-12-15
EA003256B1 (ru) 2003-02-27
HU224422B1 (hu) 2005-08-29
HK1029599A1 (en) 2001-04-06

Similar Documents

Publication Publication Date Title
DK1093383T3 (da) Lægemiddelafgivelsessystem omfattende et homeobox-peptid og et cytotoksisk eller antineoplastisk lægemiddel
ES2147553T3 (es) Vectores virales recombinantes para la expresion en unas celulas musculares.
PT1034185E (pt) Composicoes farmaceuticas que contem a pentraxina longa ptx3
MX9800719A (es) Proteinas de transporte y sus usos.
EP1024197A3 (en) Mesothelial cell gene therapy
TR199902053T2 (xx) Prostat kanserinin immunoterapisine y�nelik bile�ikler ve bunlar�n kullan�lmas�na matuf metodlar.
ES2155702T3 (es) Construcciones expresivas halteroformes para la terapia genetica.
FI932678A0 (fi) Pao alfavirus baserande DNA expressionssystem
ATE293700T1 (de) Adenovirus mit glutathion peroxydate gene
EE200000102A (et) Meetodid ja kompositsioonid teraapiaks, kasutades sekreteeritavaid valke, näiteks interferoon-beetat kodeerivaid geene
ZA200108414B (en) Akt nucleic acids, polypeptides, and uses thereof.
DE69734574D1 (de) Rekombinante adenovirenvektoren zur gentherapie der menschlichen krebse
ATE247978T1 (de) Verwendung von ompa enterobakterproteinen um zielgerichtet antigen-präsentierende zellen anzusteuern
DE69903559D1 (de) Verwendung von neuen zelltod inducierenden mitteln im synergismus mit interferon
DE60035504D1 (de) Verfahren für die verabreichung von heilmitteln mittels einer dextrinlösung
MX9701783A (es) Proteinas c3 humanas modificadas.
TR199701225A2 (xx) Gen terapisi için katyonik lipidler.